BenchSci
Exponentially increase the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence.
About BenchSci
Scientists often spend weeks or even months sifting through research to figure out which reagents to use in specific experiments. Not only is that an inefficient process, it often doesn’t work. BenchSci’s AI-assisted platform solves this challenge by automatically ingesting and interpreting millions of historical experiments from around the world saving scientists time and money and leading to more successful experiments.
We strongly believe that opportunities within the preclinical R&D market remain largely untapped and the BenchSci team is extending the impact of its industry-leading software by driving a suite of new applications that help scientists optimize their experiment designs to maximize their chances for success.
Company Information
Headquarters: Toronto
Investment Information
Investment year: 2018
Inovia Team Members: Dennis Kavelman Mia Morisset Steven Chung